Diseases like cancer or neurodegeneration are known to arise from genetic misfires. But treating such complex conditions hasn ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...

At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ...

A new Nature study suggests DNA mutations in immune cells may drive autoimmune diseases by removing immune system brakes, ...

A clinician-led approach boosts genetic testing among relatives of people with newly detected pathogenic variants — and could help close a gap in hereditary cancer prevention.

An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...

The Yvonne Ashley Galiber Breast Cancer Foundation will host its first Breast & Prostate Cancer Conference on St. Croix on ...

A new platform for studying mtDNA mutations implicated in human disease could help accelerate treatments for mitochondrial ...

PerturbFate can systematically map how diverse disease-associated genetic variations reshape cells to understand complex diseases, like cancer.

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

The 63-year-old "Oslo patient" is considered to be in remission from HIV ...

Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a small fraction of cancer cells become harder to kill. A new study from ...